| Citation: |
GUO Ping, CHEN Jian, WANG Huaqiang, GE Kaijie. Effect of PRMT5 Expression Knockdown on Proliferation, Invasion and Apoptosis of Gastric Cancer Cells and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 757-761. DOI: 10.3971/j.issn.1000-8578.2021.21.0443
|
To observe the expression level of PRMT5 in gastric cancer cells, and explore the effect of knocking down the expression level of PRMT5 on the biological behavior of gastric cancer cells.
Western blot was used to detect the expression of PRMT5 protein in gastric cancer cell lines MGC803, SGC7901, MKN45 and human gastric epithelial cells GES-1. siRNA1 and siRNA2 plasmids were transfected to knock down the expression of PRMT5. Cell proliferation and apoptosis assay, transwell assay were used to detect cell proliferation, apoptosis and invasion abilities, respectively. The protein expression levels of β-catenin, cyclin D1 and Bax were detected.
Compared with GES-1 cells, PRMT5 protein expression levels increased in MGC803, SGC7901 and MKN45 cells (P < 0.001). After knocking down the expression of PRMT5, the cell proliferation and invasion abilities were weakened, the apoptosis rate increased (P < 0.05), the expression of β-catenin and Cyclin D1 protein decreased, and the expression of Bax protein increased (P < 0.001).
The expression level of PRMT5 is increased in gastric cancer cells. Knockdown of PRMT5 expression level could inhibit cell proliferation, invasion and promote cell apoptosis via reducing Wnt/β-catenin signaling pathway.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
| [2] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90. doi: 10.3322/caac.20107
|
| [3] |
Riquelme I, Saavedra K, Espinoza JA, et al. Molecular classification of gastric cancer: towards a pathway-driven targeted therapy[J]. Oncotarget, 2015, 6(28): 24750- 24779. doi: 10.18632/oncotarget.4990
|
| [4] |
Stopa N, Krebs JE, Shechter D. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond[J]. Cell Mol Life Sci, 2015, 72(11): 2041-2059. doi: 10.1007/s00018-015-1847-9
|
| [5] |
Wei TY, Juan CC, Hisa JY, et al. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade[J]. Cancer Sci, 2012, 103(9): 1640-1650. doi: 10.1111/j.1349-7006.2012.02367.x
|
| [6] |
Bao X, Zhao S, Liu T, et al. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer[J]. J Histochem Cytochem, 2013, 61(3): 206-217. doi: 10.1369/0022155413475452
|
| [7] |
Gu Z, Gao S, Zhang F, et al. Protein arginine methyltransferase 5 is essential for growth of lung cancer cells[J]. Biochem J, 2012, 446(2): 235-241. doi: 10.1042/BJ20120768
|
| [8] |
Qin Y, Hu Q, Xu J, et al. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis[J]. Cell Commun Signal, 2019, 17(1): 30. doi: 10.1186/s12964-019-0344-4
|
| [9] |
Radzisheuskaya A, Shliaha PV, Grinev V, et al. PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia[J]. Nat Struct Mol Biol, 2019, 26(11): 999-1012. doi: 10.1038/s41594-019-0313-z
|
| [10] |
Ge L, Wang H, Xu X, et al. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells[J]. J Cell Mol Med, 2020, 24(2): 1969-1979. doi: 10.1111/jcmm.14894
|
| [11] |
Wang Y, Li Y, He H, et al. Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498[J]. Gene, 2019, 720: 144099. doi: 10.1016/j.gene.2019.144099
|
| [12] |
Lu X, Fernando TM, Lossos C, et al. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival[J]. Blood, 2018, 132(19): 2026-2039. doi: 10.1182/blood-2018-02-831438
|
| [13] |
Demetriadou C, Pavlou D, Mpekris F, et al. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression[J]. Cell Death Dis, 2019, 10(3): 236. doi: 10.1038/s41419-019-1487-3
|
| [14] |
Kumar B, Yadav A, Brown NV, et al. Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status[J]. Oncotarget, 2017, 8(9): 14847-14859. doi: 10.18632/oncotarget.14682
|
| [15] |
Ibrahim R, Matsubara D, Osman W, et al. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition[J]. Hum Pathol, 2014, 45(7): 1397-1405. doi: 10.1016/j.humpath.2014.02.013
|
| [16] |
Shilo K, Wu X, Sharma S, et al. Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors[J]. Diagn Pathol, 2013, 8: 201. doi: 10.1186/1746-1596-8-201
|
| [17] |
Chung J, Karkhanis V, Baiocchi RA, et al. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling[J]. J Biol Chem, 2019, 294(19): 7692-7710. doi: 10.1074/jbc.RA119.007640
|
| [18] |
Song Y, Li ZX, Liu X, et al. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation[J]. Tumour Biol, 2017, 39(7): 1010428317712617. https://pubmed.ncbi.nlm.nih.gov/28671020/
|
| [19] |
Wang W, Li Q, Yang T, et al. Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/β-catenin pathway[J]. Cytotechnology, 2018, 70(2): 615-624. doi: 10.1007/s10616-017-0147-7
|
| [20] |
Karkhanis V, Alinari L, Ozer HG, et al. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma[J]. J Biol Chem, 2020, 295(5): 1165-1180. doi: 10.1016/S0021-9258(17)49877-2
|
| [21] |
Gao J, Zhao C, Liu Q, et al. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1[J]. J Exp Clin Cancer Res, 2018, 37(1): 317. doi: 10.1186/s13046-018-0973-2
|
| [22] |
Hu Y, Yu K, Wang G, et al. Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell[J]. Biochem Pharmacol, 2018, 150: 280-292. doi: 10.1016/j.bcp.2018.02.023
|
Figures(6)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: